Chemical Component Summary

Nameethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
SynonymsRetigabine; Ezogabine
Identifiersethyl ~{N}-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
FormulaC16 H18 F N3 O2
Molecular Weight303.33
TypeNON-POLYMER
Isomeric SMILESCCOC(=O)Nc1ccc(cc1N)NCc2ccc(cc2)F
InChIInChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)
InChIKeyPCOBBVZJEWWZFR-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count40
Chiral Atom Count0
Bond Count41
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB04953 
NameEzogabine
Groups
  • approved
  • investigational
DescriptionEzogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine.
Synonyms
  • ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate
  • N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester
  • RTG
  • N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
  • Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
Brand Names
  • Trobalt
  • Potiga
IndicationAdjuvant treatment of partial-onset seizures.
Categories
  • Acids, Acyclic
  • Amines
  • Aniline Compounds
  • Anticonvulsants
  • Central Nervous System Agents
ATC-CodeN03AX21
CAS number150812-12-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Potassium voltage-gated channel subfamily KQT member 2MVQKSRNGGVYPGPSGEKKLKVGFVGLDPGAPDSTRDGALLIAGSEAPKR...unknown
Potassium voltage-gated channel subfamily KQT member 3MGLKARRAAGAAGGGGDGGGGGGGAANPAGGDAAAAGDEERKVGLAPGDV...unknown
Potassium voltage-gated channel subfamily KQT member 4MAEAPPRRLGLGPPPGDAPRAELVALTAVQSEQGEAGGGGSPRRLGLLGS...unknown
Potassium voltage-gated channel subfamily KQT member 5MPRHHAGGEEGGAAGLWVKSGAAAAAAGGGRLGSGMKDVESGRGRVLLNS...unknown
UDP-glucuronosyltransferase 1-1MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDYETJUF01
PubChem121892
ChEBICHEBI:68584
ChEMBLCHEMBL41355
PharosCHEMBL41355